PT - JOURNAL ARTICLE AU - Humphrey, Gayl AU - Keane, Celia AU - Gharibans, Armen AU - Andrews, Christopher N. AU - Benitez, Alain AU - Mousa, Hayat AU - O’Grady, Gregory TI - DESIGNING, DEVELOPING AND VALIDATING A SET OF STANDARDIZED PEDIATRIC PICTOGRAMS TO SUPPORT PEDIATRIC-REPORTED GASTRODUODENAL SYMPTOMS AID - 10.1101/2023.08.14.23294049 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.14.23294049 4099 - http://medrxiv.org/content/early/2023/08/16/2023.08.14.23294049.short 4100 - http://medrxiv.org/content/early/2023/08/16/2023.08.14.23294049.full AB - Objective To develop and validate a set of static and animated pediatric gastroduodenal symptom pictograms.Methods There were three study phases: 1: Co-creation used experience design methods resulting in ten pediatric gastroduodenal symptom pictograms (static and animation); 2: an online survey to assess acceptability, face and content validity; and 3: a preference study. Phases 2 and 3 compared the novel paediatric pictograms with existing pictograms used with adult patients.Results Eight children aged 6-15 years (5 Female) participated in Phase 1, 69 children in Phase 2 (median age 13 years: IQR 9-15), and an additional 49 participants were included in Phase 3 (median age 15: IQR 12-17). Face and content validity were higher for the pediatric and animated pictogram sets compared to pre-existing adult pictograms (78% vs. 78% vs. 61%). Participants with worse gastric symptoms (lower PedsQL-GIS score) had superior comprehension of the pediatric pictograms (χ28 < .001). The pediatric pictogram set was preferred by all participants over animation and adult (χ22 < .001).Conclusion The co-creation phase resulted in the symptom concept confirmation and design of ten acceptable static and animated gastroduodenal pictograms with high face and content validity when evaluated with children aged 6 to 18. Validity was superior when children reported more problematic symptoms. Therefore, these pictograms could be used in clinical and research practice to enable standardized symptom reporting for children with gastroduodenal disorders.Why is it important▪ Diagnosis of gastroduodenal disorders of the gut-brain interaction (DGBI) in pediatrics is difficult as symptoms often overlap.▪ Pediatric patients find identifying and distinguishing symptoms difficult.▪ Validated gastroduodenal symptom pictograms have been found to help adults accurately report their symptoms and have been used effectively to standardize symptom monitoring, including continuous symptom reporting during investigations.▪ There are no validated pediatric gastroduodenal symptom pictograms.What we did▪ Co-created a set of ten pediatric gastroduodenal symptom pictograms.▪ Undertook a face and content validity study to assess the novel pictograms with 118 pediatric participants with a median PedsQL-GIS score of 86.1 (IQR 68.1-90.0).The Outcome▪ Designed a novel set of pictograms with face and content validity that were preferred over other sets, enabling acceptable, simple and validated pediatric patient reporting of their gastroduodenal symptoms.Competing Interest StatementGO'G and AG hold grants and intellectual property in gastrointestinal electrophysiology. G'OG, AG, and CNA are shareholders and or employees of Alimetry. GO'G is a Director at The Insides Company. The remaining authors have no conflicts of interest to declare.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the New Zealand Health and Disability Ethics Committee gave approval for this researchI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData sharing and data use are governed by the Aotearoa | New Zealand Health and Disability Ethics Committee. The majority of the data is available in the manuscript; however, all requests for additional data can be made to the corresponding author. Requests will be granted if the proposed use aligns with the ethical approval for the study and has obtained relevant ethical approvals, including approval from a NZ Ethical Committee.